Cite
HARVARD Citation
Herranz, C. et al. (2021). Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis. EMBO molecular medicine. 13 (9), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Herranz, C. et al. (2021). Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis. EMBO molecular medicine. 13 (9), p. n/a. [Online].